Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Luis Borges Insider Profile
4 Followers
Luis Borges, SVP, Research at Five Prime Therapeutics, holds 69.32K shares in Metagenomi, Inc. (Ticker: MGX), holds 256.54K shares in Century Therapeutics (Ticker: IPSC), holds 71.62K shares in Five Prime Therapeutics (Ticker: FPRX).
Luis Borges Five Prime Therapeutics (FPRX)SVP, Research
Five Prime Therapeutics (FPRX)
SVP, Research
Not Ranked
Luis Borges has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Luis Borges holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 05, 2023 - Apr 05, 2024
Return:+13.00%
The most profitable trade made by Luis Borges
Luis Borges's Trading History
Five Prime Therapeutics
Mar 03, 2017
―
Uninformative Sell
809.62K
$2.72M
Century Therapeutics
Apr 05, 2023
CSO
Informative Buy
7.68K
$800.39K
Metagenomi, Inc.
Apr 03, 2024
Chief Scientific Officer
Uninformative Buy
―
$460.26K
List of latest transactions for each holding click on a transaction to see Luis Borges's performance on stock
You May Also Like
Luis Borges insider profile FAQ
What is the percentage of profitable transactions made by Luis Borges?
The percentage of profitable transactions made by Luis Borges is ―.
What is the average return per transaction made by Luis Borges?
The average return per transaction made by Luis Borges is ―.
What stocks does Luis Borges hold?
Luis Borges holds: FPRX, IPSC, MGX stocks.
What was Luis Borges’s latest transaction?
Luis Borges latest transaction was an Uninformative Buy of ―.
What was Luis Borges's most profitable transaction?
Luis Borges’s most profitable transaction was an Informative Buy of IPSC stock on April 5, 2023. The return on the trade was 13.00%.
What is Luis Borges's role in Five Prime Therapeutics?
Luis Borges's role in Five Prime Therapeutics is SVP, Research.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.